A61K 9/4841
Filling excipients
Official title: {Filling excipients; Inactive ingredients}
A61K9/4841 (Filling excipients) appears on 4,009 US grants and 7,181 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,009
- Published applications
- 7,181
- Assignees
- 2,622
- Inventors
- 11,539
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 3 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 8 | 0 |
| 1981 | 4 | 0 |
| 1982 | 7 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 7 | 0 |
| 1986 | 8 | 0 |
| 1987 | 15 | 0 |
| 1988 | 14 | 0 |
| 1989 | 22 | 0 |
| 1990 | 18 | 0 |
| 1991 | 11 | 0 |
| 1992 | 13 | 0 |
| 1993 | 13 | 0 |
| 1994 | 17 | 0 |
| 1995 | 13 | 0 |
| 1996 | 25 | 0 |
| 1997 | 28 | 0 |
| 1998 | 31 | 0 |
| 1999 | 74 | 0 |
| 2000 | 42 | 0 |
| 2001 | 81 | 29 |
| 2002 | 62 | 83 |
| 2003 | 62 | 171 |
| 2004 | 46 | 153 |
| 2005 | 56 | 153 |
| 2006 | 56 | 144 |
| 2007 | 29 | 140 |
| 2008 | 34 | 164 |
| 2009 | 21 | 166 |
| 2010 | 66 | 185 |
| 2011 | 64 | 182 |
| 2012 | 91 | 231 |
| 2013 | 137 | 276 |
| 2014 | 168 | 362 |
| 2015 | 228 | 387 |
| 2016 | 216 | 395 |
| 2017 | 237 | 421 |
| 2018 | 202 | 379 |
| 2019 | 259 | 416 |
| 2020 | 241 | 474 |
| 2021 | 260 | 485 |
| 2022 | 256 | 398 |
| 2023 | 202 | 389 |
| 2024 | 208 | 412 |
| 2025 | 195 | 358 |
| 2026 | 127 | 228 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- API stability in softgels29 Sep 2026US 12,746,206 B2R.P. Scherer Technologies, LLC
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Cabozantinib compositions and methods of use22 Sep 2026US 12,741,938 B2Handa Oncology, LLC
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Pharmaceutical preparation and method for producing the same15 Sep 2026US 12,734,163 B2Fuji Pharma Co., Ltd.
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- Hydrogel ink, hydrogel and uses thereof8 Oct 2026US 2026/0306528 A1
- A floating drug delivery system for solid forms of salts used in bowel cleansing products8 Oct 2026US 2026/0306534 A1Dark Canyon Laboratories, LLC
- Production of a pharmaceutical dosage form from horseradish and nasturtium8 Oct 2026US 2026/0306570 A1Kwizda Pharma GmbH
- Composition containing cyclic peptide compound and surfactant1 Oct 2026US 2026/0294806 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents638US 6,383,471 B1Lipocine Inc. · 2002
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001